Congratulations, Kyle Lafata, M.D., Ph.D., on your R01 grant, issued by the National Cancer Institute. The study: "Computational tumor phenotyping to interrogate treatment resistance and immune dysregulation in head and neck cancer," aims to develop computational tumor phenotyping strategies and multi-scale mathematical methods to characterize treatment resistance of head and neck cancer.
